Oral formulations represent 43.2% of dosage form demand and big pharma accounts for 50.0% of end user sales in 2026. The drug formulation market is estimated at USD 1.8 trillion in 2026, is projected to reach USD 3.1 trillion by 2036 and is forecast to post a 5.7% CAGR between 2026 and 2036.